A cost-effectiveness analysis of MMX mesalazine compared with mesalazine in the treatment of mild-to-moderate ulcerative colitis from a UK perspective. (Q43168976)
Jump to navigation
Jump to search
scientific article published in March 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A cost-effectiveness analysis of MMX mesalazine compared with mesalazine in the treatment of mild-to-moderate ulcerative colitis from a UK perspective. |
scientific article published in March 2010 |
Statements
A cost-effectiveness analysis of MMX mesalazine compared with mesalazine in the treatment of mild-to-moderate ulcerative colitis from a UK perspective (English)
Ron Akehurst
Michael A Kamm
Nic Brereton
Paul Hodgkins